Literature DB >> 1401949

A simple fluorescence method for surface antigen phenotyping of lymphocytes undergoing DNA fragmentation.

J A Hardin1, D H Sherr, M DeMaria, P A Lopez.   

Abstract

Apoptosis, a metabolically active process of programmed cell death characterized by DNA fragmentation, is believed to play an important role in development of lymphocyte repertoires and in embryogenesis. Studies of this phenomenon would be greatly facilitated by the development of a simple assay capable of identifying and isolating intact apoptotic cells. A rapid fluorescence assay which identifies relatively small, intact cells containing fragmented DNA is described in this report. Thymocytes in which DNA fragmentation is induced by culture with or without dexamethasone are readily identified by their bright blue fluorescence after a 15 min treatment with Hoechst 33342, a DNA binding fluorochrome which diffuses through cell membranes. Since Hoechst 33342 staining does not require destruction of the cell membrane, it is possible to directly phenotype cell surface antigen expression on Hoechst 33342bright lymphocytes by conventional immunofluorescence techniques and to evaluate membrane integrity of Hoechst 33342bright cells by dye exclusion criteria. The advantages of this system are that it: (1) is rapid and simple, (2) quantitates the percentage of cells fragmenting their DNA and presumably undergoing apoptosis, (3) permits standard immunofluorescence staining of cell surface markers to identify even minor cell subsets of presumably apoptotic cells within heterogeneous populations, (4) provides the tools (fluorescence activated cell sorting) for purifying intact cells containing fragmented DNA for further biochemical studies, and (5) provides a means for identifying cells which exclude vital dyes and in which DNA fragmentation will eventually result in cell death.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1401949     DOI: 10.1016/0022-1759(92)90217-h

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  7 in total

1.  Defining the heterogeneity of skeletal muscle-derived side and main population cells isolated immediately ex vivo.

Authors:  Kristen M Kallestad; Linda K McLoon
Journal:  J Cell Physiol       Date:  2010-03       Impact factor: 6.384

2.  CTLA4 mediates antigen-specific apoptosis of human T cells.

Authors:  J G Gribben; G J Freeman; V A Boussiotis; P Rennert; C L Jellis; E Greenfield; M Barber; V A Restivo; X Ke; G S Gray
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

3.  Detection and quantification of live, apoptotic, and necrotic human peripheral lymphocytes by single-laser flow cytometry.

Authors:  T J Liegler; W Hyun; T S Yen; D P Stites
Journal:  Clin Diagn Lab Immunol       Date:  1995-05

4.  Glucose promotes survival of rat pancreatic beta cells by activating synthesis of proteins which suppress a constitutive apoptotic program.

Authors:  A Hoorens; M Van de Casteele; G Klöppel; D Pipeleers
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

5.  Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections.

Authors:  J Estaquier; T Idziorek; F de Bels; F Barré-Sinoussi; B Hurtrel; A M Aubertin; A Venet; M Mehtali; E Muchmore; P Michel; Y Mouton; M Girard; J C Ameisen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

6.  Arsenic trioxide overcomes rapamycin-induced feedback activation of AKT and ERK signaling to enhance the anti-tumor effects in breast cancer.

Authors:  Cynthia Guilbert; Matthew G Annis; Zhifeng Dong; Peter M Siegel; Wilson H Miller; Koren K Mann
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

7.  Monitoring Response and Resistance to the Novel Arsenical Darinaparsin in an AML Patient.

Authors:  Torsten H Nielsen; Nathalie Johnson; Nicolas Garnier; Stanley Kwan; Lu Yao; Eftihia Cocolakis; Josée Hébert; Robert A Morgan; Eric Paquet; Kevin P Callahan; Craig T Jordan; Sarit Assouline; Wilson H Miller; Koren K Mann
Journal:  Front Pharmacol       Date:  2013-02-12       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.